Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interleukin 6 in diabetes, chronic kidney disease, and cardiovascular disease: mechanisms and therapeutic perspectives
Frederik Flindt Kreiner, Jordan M. Kraaijenhof, Matthias von Herrath, et al.
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 4, pp. 377-389
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association
Carmine Zoccali, Francesca Mallamaci, Marcin Adamczak, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 11, pp. 2017-2032
Open Access | Times Cited: 102
Mechanisms of wogonoside in the treatment of atherosclerosis based on network pharmacology, molecular docking, and experimental validation
Zhaohui Gong, Haixin Yang, Li Gao, et al.
BMC Complementary Medicine and Therapies (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 3
Diabetic complications and prospective immunotherapy
Lewis Reynolds, Zhengkang Luo, K. N. Singh
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
Systematic Review on the Role of IL-6 and IL-1β in Cardiovascular Diseases
Nurlubek Katkenov, Zhussipbek Mukhatayev, Samat Kozhakhmetov, et al.
Journal of Cardiovascular Development and Disease (2024) Vol. 11, Iss. 7, pp. 206-206
Open Access | Times Cited: 8
Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS
Akihiko Koshino, Meir Schechter, Taha Sen, et al.
Diabetes Care (2022) Vol. 45, Iss. 11, pp. 2644-2652
Open Access | Times Cited: 31
IL-38 in modulating hyperlipidemia and its related cardiovascular diseases
Min Lai, Hua Peng, Xijie Wu, et al.
International Immunopharmacology (2022) Vol. 108, pp. 108876-108876
Closed Access | Times Cited: 28
Butterfly pea flower (Clitoria ternatea L.) extract displayed antidiabetic effect through antioxidant, anti-inflammatory, lower hepatic GSK-3β, and pancreatic glycogen on Diabetes Mellitus and dyslipidemia rat
Wahyu Widowati, Lusiana Darsono, Johan Lucianus, et al.
Journal of King Saud University - Science (2023) Vol. 35, Iss. 4, pp. 102579-102579
Open Access | Times Cited: 16
Anemia in Diabetes Mellitus: pathogenetic aspects and the value of early erythropoietin therapy
Christina Antoniadou, Efstratios Gavriilidis, Konstantinos Ritis, et al.
Metabolism Open (2025) Vol. 25, pp. 100344-100344
Open Access
Advances in kidney disease: pathogenesis and therapeutic targets
Vincent Boima, Alex Baafi Agyekum, Khushali Ganatra, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Crosstalk between ferroptosis and innate immune in diabetic kidney disease: mechanisms and therapeutic implications
Jinyang Wang, Haonan Shi, Ye Seul Yang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
A wearable graphene transistor-based biosensor for monitoring IL-6 biomarker
Kaitlyn E. Laliberte, Patrick G. Scott, Niazul Islam Khan, et al.
Microelectronic Engineering (2022) Vol. 262, pp. 111835-111835
Open Access | Times Cited: 23
Saracatinib, a Src kinase inhibitor, enhances the renoprotective effect of metformin and losartan in diabetic nephropathy
Suzan A. Khodir, Eman Sweed, Mona A. Kora, et al.
Archives of Physiology and Biochemistry (2025), pp. 1-16
Closed Access
Assessment of bacteriological and immunological markers in urinary tract infection and the effect of antibiotics on the isolated bacteria
Wisam F. Hameed, Bashar Sadeq Noomi, Abd Al. Kareem Khaleel, et al.
Cellular and Molecular Biology (2025) Vol. 70, Iss. 12, pp. 125-134
Closed Access
Decoding Health: Exploring Essential Biomarkers Linked to Metabolic Dysfunction-Associated Steatohepatitis and Type 2 Diabetes Mellitus
Sulagna Mukherjee, Seung‐Soon Im
Biomedicines (2025) Vol. 13, Iss. 2, pp. 359-359
Open Access
Neuroinflammation in kidney disease and dialysis
Yumi Watanabe Chagas, Pedro Alves Soares Vaz de Castro, Ana Cristina Simões e Silva
Behavioural Brain Research (2025) Vol. 483, pp. 115465-115465
Closed Access
Cytokine Signaling in Diabetic Neuropathy: A Key Player in Peripheral Nerve Damage
Zahra Nashtahosseini, Majid Eslami, Elham Paraandavaji, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 589-589
Open Access
Dapagliflozin in Chronic Kidney Disease: Insights from Network Pharmacology and Molecular Docking Simulation
Atthaphong Phongphithakchai, Aman Tedasen, Ratana Netphakdee, et al.
Life (2025) Vol. 15, Iss. 3, pp. 437-437
Open Access
Interleukin-6 in Heart Failure With Reduced Ejection Fraction and the Effect of Dapagliflozin
Kieran F. Docherty, Kirsty McDowell, Paul Welsh, et al.
JACC Heart Failure (2025)
Open Access
Targeting Inflammatory Imbalance in Chronic Kidney Disease: Focus on Anti-Inflammatory and Resolution Mediators
Rosaria Margherita Rispoli, Ada Popolo, Vincenzo De Fabrizio, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3072-3072
Open Access
Increased Expression of Circulating Stress Markers, Inflammatory Cytokines and Decreased Antioxidant Level in Diabetic Nephropathy
Ghazal Mansoor, Muhammad Bilal Tahir, Tahir Maqbool, et al.
Medicina (2022) Vol. 58, Iss. 11, pp. 1604-1604
Open Access | Times Cited: 19
The effect of sodium-glucose co-transporter-2 (SGLT2) inhibitors on blood interleukin-6 concentration: a systematic review and meta-analysis of randomized controlled trials
Sepehr Gohari, Faramarz Ismail‐Beigi, Mahsa Mahjani, et al.
BMC Endocrine Disorders (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Type 2 Diabetes and the Microbiome
Gillian Barlow, Ruchi Mathur
Journal of the Endocrine Society (2022) Vol. 7, Iss. 2
Open Access | Times Cited: 16
Immunomodulatory performance of GMP-compliant, clinical-grade mesenchymal stromal cells from four different sources
Mandana Kazem Arki, Kasra Moeinabadi‐Bidgoli, Bahareh Niknam, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24948-e24948
Open Access | Times Cited: 3
Berberine: A Multi-Target Natural PCSK9 Inhibitor with the Potential to Treat Diabetes, Alzheimer’s, Cancer and Cardiovascular Disease
Caroline Coppinger, Briana Pomales, Mohammad Reza Movahed, et al.
Current Reviews in Clinical and Experimental Pharmacology (2024) Vol. 19, Iss. 4, pp. 312-326
Open Access | Times Cited: 3
Sliding Microneedle - Lateral flow immunoassay strip device for highly sensitive biomarker detection in interstitial fluid
Ga Ram Yang, Woo Jin Kim, Jae Hwan Jung
Biosensors and Bioelectronics (2024) Vol. 263, pp. 116590-116590
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top